Resources Contact Us Home
A.sub.3 adenosine receptor agonists

Image Number 6 for United States Patent #5688774.

The present invention provides A.sub.3 selective agonists, particularly, adenine compounds having selected substituents at the 2, 6, and 9 positions, and related substituted compounds, particularly those containing substituents on the benzyl and/or uronamide groups, as well as pharmaceutical compositions containing such compounds. The present invention also provides a method of selectively activating an A.sub.3 adenosine receptor in a mammal, which method comprises acutely or chronically administering to a mammal in need of selective activation of its A.sub.3 adenosine receptor a therapeutically or prophylactically effective amount of a compound which binds with the A.sub.3 receptor so as to stimulate an A.sub.3 receptor-dependent response.

  Recently Added Patents
Method for forming contact in an integrated circuit
Conductive polymer and a solid electrolytic capacitor using the same as a solid electrolyte
Inhibitors of human immunodeficiency virus replication
Circuit board and display panel assembly having the same
Shared system to operationally connect logic nodes
DNA promoters and anthrax vaccines
Transaction finance processing system and approach
  Randomly Featured Patents
Method and apparatus for filtering error logs in a logically partitioned data processing system
Single gripper conveyor system
Isoquinolinium substituted cephalosporins
.alpha.-Glucosidase inhibitors from a natural source
Process for fabricating interconnection of semiconductor device
Sleeve for storing a disc shaped object
Variable drop volume continuous liquid jet printing
Magnetic doorstop
Semiconductor integrated circuit device and its manufacturing method
Method and arrangement for performing positioning